Skip to content
Use caution Drug recall · FDA · Published April 30, 2012

Apotex Recalls Eye Drops Due to Particulate Matter

Apotex recalls Dorzolamide HCI/Timolol Maleate eye drops because lots may contain small particulates. Check your bottle lot numbers and expiration date.

🇺🇸 FDA recall #D-1439-2012DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. has recalled Dorzolamide HCI/Timolol Maleate Ophthalmic Solution in 10mL bottles due to the potential presence of particulate matter. The affected products were distributed nationwide and in Puerto Rico. The recall covers specific lots with an expiration date of June 2012. Read more at govinfonow.com/recall/48913-apotex-inc-recalls-dorzolamide-hci-timolol-maleate-ophthalmic-solution-22.

Source Summary by GovInfoNow · govinfonow.com/recall/48913-apotex-inc-recalls-dorzolamide-hci-timolol-maleate-ophthalmic-solution-22 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1439-2012

Cite this page

“Apotex Recalls Eye Drops Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48913-apotex-inc-recalls-dorzolamide-hci-timolol-maleate-ophthalmic-solution-22. Based on FDA recall #D-1439-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1439-2012%22&limit=1).

The FDA announced on April 30, 2012, that Apotex Inc. is recalling Dorzolamide HCI/Timolol Maleate Ophthalmic Solution due to the presence of particulate matter. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Apotex
  • Product: Dorzolamide HCI/Timolol Ophthalmic Solution
  • Strength: 22.3mg/6.8mg per mL
  • Size: 10mL bottle
  • Lot codes: JN1060, JN1061, JN1062
  • Expiration date: 06/12
  • Units affected: 119,794 bottles
  • Distribution: Nationwide and Puerto Rico

The hazard

The recall notification states that lots identified in this recall may contain small particulates. The FDA classified the hazard as Class II.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since June 25, 2013. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apotex Rite Aid Maximum Strength Ranitidine Tablets Recall (Sept. 24, 2019). Other recent recalls of similar products include Apotex Brimonidine/Timolol Eye Drops Recall (March 5, 2026), Clear Eyes Eye Drops Recalled for Sterility Risk (July 29, 2026), and Rohto Cooling Eye Drops Recall (July 14, 2026).

How to tell if you have this one

Look for a 10mL bottle labeled 'Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL'. Check the lot numbers on the packaging; affected lots are JN1060, JN1061, and JN1062. The expiration date on these bottles is June 2012 (Exp 06/12).

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches the description and has one of the affected lot numbers (JN1060, JN1061, or JN1062) with an expiration date of 06/12.

  2. Contact Your Pharmacist

    If you have the affected product, contact your pharmacist or healthcare provider for instructions on how to return or dispose of the medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Apr 30, 201212. FDA classified it Class II: Aug 2, 201223. Published in FDA’s Enforcement Report: Aug 8, 201234. FDA terminated the recall: Sep 19, 2013420122013
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1439-2012 (April 30, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1439-2012 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA